Delivery Order SPE2DB24D2205-SPE2DB25FEEZE
Award Date 7/16/25
Potential Completion Date 8/6/25
Potential Value $34K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Takhzyro 300 mg/2 ml syringes with a ceiling value of $34,342.56. This firm fixed-price delivery order is scheduled for completion by September 15, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The contract was awarded on a competitive basis with no set-aside designation. This delivery order operates under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $34,342.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Takhzyro 300 mg/2 ml syringes on April 25, 2025, with completion required by May 16, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively granted with no set-aside designation, and...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,448.80 firm fixed-price delivery order is for the supply of TAKHZYRO 300 MG/2 ML syringes, a specialty medication used for the treatment of hereditary angioedema. The award has an ultimate completion date of May 14, 2024 and was made on April 23, 2024. This delivery order is a part of Amerisourcebergen's...
- Amerisourcebergen Drug Corporation, operating as a division of Amerisourcebergen Corporation, has been awarded a $31,755.04 firm fixed price delivery order contract by the Defense Logistics Agency Troop Support Medical to provide TAKHZYRO 300 MG/2 ML syringes. Performance will take place in Conshohocken, Pennsylvania over a period spanning from June 28, 2023 through July 20, 2023. The Defense Logistics Agency Troop Support Medical, which supports the medical supply needs of the U.S. Department...
- This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $34,342.56, is for the delivery of TAKHZYRO 300 MG/2 ML SYRINGE 2ML, a specialty medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 18, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency Troop Support Medical awarded a $31,755 delivery order to Amerisourcebergen Drug Corp for the supply of 300 mg/2 ml syringes of Takhzyro, a medication used to treat hereditary angioedema. Performance will take place in Conshohocken, Pennsylvania under a firm fixed price contract spanning August 10 to August 31, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corp, the prime contractor selected to fulfill DLA's requirements for this...
- This federal contract award, valued at $32,448.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TAKHZYRO 300 MG/2 ML SYRINGE 2ML, a specialty medication, with a completion date of April 30, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,342.56 firm fixed price delivery order is for TAKHZYRO 300 MG/2 ML SYRINGE 2ML, a specialty pharmaceutical product. The contract has an ultimate completion date of March 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TAKHZYRO 300 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a ceiling value of $34,342.56 and a completion date of June 20, 2025. The contract is a firm-fixed-price delivery order, indicating the government is acquiring a specific quantity of a commercial product at an established price....
- This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical drug Takhzyro, a treatment for hereditary angioedema. The $32,448.80 firm fixed price delivery order was placed by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 30, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...